DHLs with c-MYC/BCL2 rearrangement showed TP53 mutation frequency intermediate between DLBCL and BL, while TP53 mutations were scarce in DHLs with c-MYC/BCL6 rearrangement. The gene discussed is BCL2; the disease is Burkitt lymphoma.